United States· US:17089-231_ed6d4807-3581-421a-e053-2995a90a1f54

GUNA-FEM

A melatonin receptor agonists product containing adenosinum ciclophosphoricum - lilium tigrinum - melatonin - sus scrofa adrenal gland - sus scrofa corpus luteum - sus scrofa hypothalamus - sus scrofa ovary - sus scrofa pancreas - sus scrofa pineal gland - sus scrofa pituitary gland - sus scrofa thymus - thyroid -, registered in United States by Guna spa.

ATC N05CHUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedGUNA-FEMATCN05CHREGISTER NO.US:17089-231_ed6d4807…PACKS LISTED1CHECKEDJune 3, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ADENOSINUM CICLOPHOSPHORICUM - LILIUM TIGRINUM - MELATONIN - SUS SCROFA ADRENAL GLAND - SUS SCROFA CORPUS LUTEUM - SUS SCROFA HYPOTHALAMUS - SUS SCROFA OVARY - SUS SCROFA PANCREAS - SUS SCROFA PINEAL GLAND - SUS SCROFA PITUITARY GLAND - SUS SCROFA THYMUS - THYROID -
Manufacturer
Guna spa
Country
United States (US)
ATC code
N05CH
ATC class
Melatonin receptor agonists
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 3, 2026

Packs & prices · 1

  • ndc11
    1708923118
    1 BOTTLE, DROPPER in 1 BOX (17089-231-18) / 30 mL in 1 BOTTLE, DROPPER

Regulatory notes

UNII (FDA substance ID)
E0399OZS9N
ADENOSINE CYCLIC PHOSPHATE
RxCUI 1314330

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/687ad663-97a0-4f9e-8cbf-c6dd45db0342
GET /v1/drugs/687ad663-97a0-4f9e-8cbf-c6dd45db0342?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "E0399OZS9N",
    "rxcui": "1314330",
    "inchikey": "IVOMOUWHDPKRLL-KQYNXXCUSA-N",
    "display_name": "ADENOSINE CYCLIC PHOSPHATE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "productid": "17089-231_ed6d4807-3581-421a-e053-2995a90a1f54",
  "productndc": "17089-231",
  "dosage_form": "SOLUTION/ DROPS",
  "dea_schedule": null,
  "product_type": "HUMAN OTC DRUG",
  "substance_name": "ADENOSINE CYCLIC PHOSPHATE; LILIUM LANCIFOLIUM BULB; MELATONIN; SUS SCROFA ADRENAL GLAND; SUS SCROFA CORPUS LUTEUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYMUS; THYROID",
  "proprietary_name": "GUNA-FEM",
  "active_ingred_unit": "[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL",
  "application_number": null,
  "marketing_category": "UNAPPROVED HOMEOPATHIC",
  "nonproprietary_name": "ADENOSINUM CICLOPHOSPHORICUM - LILIUM TIGRINUM - MELATONIN - SUS SCROFA ADRENAL GLAND - SUS SCROFA CORPUS LUTEUM - SUS SCROFA HYPOTHALAMUS - SUS SCROFA OVARY - SUS SCROFA PANCREAS - SUS SCROFA PINEAL GLAND - SUS SCROFA PITUITARY GLAND - SUS SCROFA THYMUS - THYROID -",
  "start_marketing_date": "20060523",
  "active_numerator_strength": "6; 6; 200; 30; 30; 30; 6; 30; 30; 30; 30; 6"
}

See everything about adenosinum ciclophosphoricum - lilium tigrinum - melatonin - sus scrofa adrenal gland - sus scrofa corpus luteum - sus scrofa hypothalamus - sus scrofa ovary - sus scrofa pancreas - sus scrofa pineal gland - sus scrofa pituitary gland - sus scrofa thymus - thyroid -.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.